Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CITRA-HDF
NCT07618858Not yet recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of trisodium citrate in end-stage kidney disease (ESKD) (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoints: Complement activation marker C3a, Platelet factor 4 and 1 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
trisodium citrate
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on NCT07618858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07618858.